Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
21JUL

Slow labs are eating DRC's Ebola wards

2 min read
09:12UTC

Patients still waiting on a laboratory result occupy between 55% and 64% of every Ebola isolation bed in DR Congo, Africa CDC found.

ScienceDeveloping
Key takeaway

Testing delay, not ward shortage, is consuming most of DR Congo's Ebola isolation capacity.

Unconfirmed suspects awaiting laboratory results occupied between 55% and 64% of every Ebola isolation bed in DR Congo through the week to 27 July, Africa CDC found 1. Most of the country's isolation capacity is therefore holding people whose infection status nobody yet knows.

Isolation exists because Ebola spreads through contact with the sick, so anyone presenting with fever, vomiting or bleeding in an affected health zone has to be separated until a polymerase chain reaction test returns a verdict. Where samples move quickly, the ward turns over: negatives go home in a day or two, positives move into treatment. Where samples queue for transport to a distant laboratory, both groups stay put. WHO granted the first Bundibugyo-specific diagnostic an Emergency Use Listing on 2 July , which fixed the question of whether a validated test existed. It did not fix the distance between a health post in Ituri and the machine that runs the assay.

A confirmed patient turned away from a full ward is a patient WHO goes home infectious, and the person occupying the bed they needed may well test negative the following morning. Every hour of laboratory delay converts directly into isolation capacity that treats nobody, which is why decentralised testing, the two mobile laboratories placed at the border among them, buys more ward space than any comparable amount of construction.

Deep Analysis

In plain English

Not everyone admitted to an Ebola isolation ward actually has Ebola. Doctors admit anyone showing symptoms first, then wait for a lab test to confirm or rule it out, because it would be too dangerous to wait for the test result before isolating someone who might be infectious. Right now, more than half of every isolation bed in the country, up to 64%, is filled by these unconfirmed patients waiting on results, rather than by patients who have already tested positive. That means confirmed patients are sometimes competing for space with people who will turn out not to have Ebola at all.

Deep Analysis
Root Causes

Isolation wards in an Ebola response admit suspects on clinical grounds before a laboratory result exists, because waiting for confirmation before isolating a symptomatic patient would let genuinely positive cases move freely in the meantime. That precautionary admission is medically necessary, but it means every bed occupied by a suspect who later tests negative was a bed a confirmed patient could not use in the interim.

Ten reference laboratories serve five affected provinces, so sample transport time between clinical suspicion and laboratory confirmation, not testing capacity itself, sets the pace at which beds turn over.

What could happen next?
  • Consequence

    Bed capacity confirmed patients need is being consumed by the testing pipeline itself, compounding the province-level bed misallocation already straining the response.

  • Opportunity

    Faster sample transport from remote health zones to the ten reference laboratories, rather than additional testing machines alone, would likely free isolation capacity fastest.

First Reported In

Update #12 · Two-thirds of Ebola deaths never reach a ward

Africa CDC· 31 Jul 2026
Read original
Causes and effects
This Event
Slow labs are eating DRC's Ebola wards
Laboratory turnaround has become a bed-capacity problem: most of the country's isolation space is holding people who may not have Ebola at all.
Different Perspectives
UK Health Security Agency
UK Health Security Agency
UKHSA said egg consumption remains the strongest signal in its 207-case Salmonella Enteritidis investigation. The genomic cluster and 38% hospitalisation among people with available information make exposure identification a public-health priority.
GLEWS+
GLEWS+
GLEWS+ assessed spillover risk from clade B MERS in Nile Basin camels as high if the clade establishes, while rating evidence for spread in camel populations low confidence. The joint assessment makes whole-genome sequencing the next test of the threat.
WHO Regional Office for Africa
WHO Regional Office for Africa
WHO's Africa office said transmission in DR Congo is outpacing control efforts after laboratory capacity reached 19 sites and treatment capacity exceeded 1,300 beds. The assessment puts access, insecurity, community deaths and late care-seeking ahead of a simple equipment shortage.
People in Guatemala
People in Guatemala
Guatemala's population now carries the region's largest reported measles burden, with 30,371 confirmed cases and 26 deaths. The scale shifts practical attention from the Mexico-centred frame that followed the World Cup's travel consequences.
Pan American Health Organization
Pan American Health Organization
PAHO rated regional measles risk very high after recording 47,459 confirmed cases and 44 deaths through week 28. It names vaccination coverage, accumulated susceptibles and mass gatherings with broad international participation as general risk factors.
Chinese health authorities
Chinese health authorities
China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.